UNC lab partnership develops first COVID-19 treatment approved by FDA

Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University. (Daily Tar Heel)

Related: Campus Connections

Ghosts of UNC's past and present
Every October, the whispers of UNC’s past seem to echo a little louder. For decades, students and staff have swapped legends of spirits that are...
Mon Nov 3, 2025

Residents flock to spooktacular Halloween celebration on Franklin Street
Hundreds of people flocked to Franklin Street on Friday to celebrate Halloween in Chapel Hill, North Carolina. The college town has been a popular spot...
Sat Nov 1, 2025

Interview with UNC Professor, Pulitzer Prize Winner Kathleen DuVal
Kathleen DuVal has a lot to say about early American history. Her latest book, Native Nations: A Millennium in North America, spans more than 700...
Fri Oct 31, 2025

'Halloweekend' in Chapel Hill, explained
Each year, the Town of Chapel Hill closes down Franklin Street for a massive impromptu parade. This tradition has been ongoing for decades and turnout...
Wed Oct 29, 2025